Sort
141,003 grants matching “cytokine”
Biology of the Lung: A Multidisciplinary Program
$721,350David M Center · Boston University Medical Campus · T32 · FY2014 · HL
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
$721,297Priscilla Y. Hsue · University Of California, San Francisco · R33 · FY2020 · HL
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
$721,297Priscilla Y. Hsue · University Of California, San Francisco · R33 · FY2021 · HL
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
$721,297Priscilla Y. Hsue · University Of California, San Francisco · R33 · FY2022 · HL
Childhood infection and prevention of obesity
$721,280Julie Parsonnet · Stanford University · R01 · FY2011 · HD
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses
$721,276Mayumi Nakagawa · Univ Of Arkansas For Med Scis · R01 · FY2020 · CA
Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses
$721,274Mayumi Nakagawa · Univ Of Arkansas For Med Scis · R01 · FY2017 · CA
Role of Follicular T Helper Cells In Enhancing Humoral Immunity and Protection
$721,267Rafi Ahmed · Emory University · U19 · FY2011 · AI
Development of an Improved Vascular Graft for Use in Congenital Heart Surgery
$721,251Christopher Kane Breuer · Research Inst Nationwide Children'S Hosp · R01 · FY2016 · HL
KLF2 is a novel endoprotective target for DKD
$721,246John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK
Origin and function of atypical lymphocyte populations in inflamed tissue in SLE and RA
$721,185Betty Diamond · Brigham And Women'S Hospital · P01 · FY2025 · AI
Chikungunya Virus Replication and Pathogenesis
$721,175Terence S. Dermody · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Dual drug delivery to lung/blood interface in respiratory infections.
$721,126Vladimir R Muzykantov · University Of Pennsylvania · R01 · FY2023 · HL
Integrated Multi-Scale Analysis of Tumor and Host Response to Therapy
$721,122Shan X. Wang · University Of Southern California · U54 · FY2011 · CA
Animal models of eye diseases
$721,120Sheldon Miller · National Eye Institute · ZIA · FY2011 · EY
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
$721,087Sanjay Srivastava · University Of Louisville · R01 · FY2021 · HL
Towards HIV eradication: New concepts and potent compounds for PKC-mediated latency reversal
$721,067Jerome A. Zack · University Of California Los Angeles · R01 · FY2025 · AI
Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans
$721,062Robert E Gerszten · Beth Israel Deaconess Medical Center · R01 · FY2020 · HL
Reversal of HIV latency by METH and Inflammation
$721,059Jonathan Karn · Case Western Reserve University · R01 · FY2020 · DA
Development of P2Y Receptor Ligands
$721,055Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Integrated Reward-Inflammation Model of First Onset of Major Depression in Adolescence
$721,036Lauren Bersh Alloy · Temple Univ Of The Commonwealth · R01 · FY2022 · MH
Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA
$721,016Vladimir P Torchilin · Northeastern University · U54 · FY2014 · CA
Microfluidic Functional Immunophenotyping of Pediatric Patients Following Cardiop
$721,014Jianping Fu · University Of Michigan At Ann Arbor · R01 · FY2014 · HL
Establishing the contributions of monogenic etiologies to hidradenitis suppurativapathogenesis
$720,985Lynn Petukhova · Columbia University Health Sciences · R01 · FY2023 · AR
Toxicant Production and Mitigation in the Electronic-Cigarette Reaction Vessel
$720,945Robert M Strongin · Portland State University · R01 · FY2017 · ES